6 insiders reported 16 Form 4 transactions for Ventyx Biosciences, Inc. (VTYX) over the past 18 months (most recent 2026-03-04). Recent activity: Nuss John (CHIEF SCIENTIFIC OFFICER) Sell 489,481 shares, Forman Mark S (Chief Medical Officer) Sell 6,000 shares, Mohan Raju (CEO AND PRESIDENT) Sell 2.4M shares, Subramaniam Somu (Director) Sell 3.3M shares, Gonzales Roy (Senior VP, Finance) Sell 5,313 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 489,481 | $0 |
| 2026-03-04 | Forman Mark S | Chief Medical Officer | Sell | 6,000 | $0 |
| 2026-03-04 | Mohan Raju | CEO AND PRESIDENT | Sell | 2.4M | $0 |
| 2026-03-04 | Subramaniam Somu | Director | Sell | 3.3M | $0 |
| 2026-03-04 | Gonzales Roy | Senior VP, Finance | Sell | 5,313 | $0 |
| 2026-03-04 | GUJRATHI SHEILA | Director | Sell | 130,000 | $0 |
| 2026-03-03 | Subramaniam Somu | Director | Sell | 694,718 | $0 |
| 2025-12-19 | Mohan Raju | CEO AND PRESIDENT | Buy | 116,668 | $0 |
| 2025-12-19 | Mohan Raju | CEO AND PRESIDENT | Sell | 47,345 | $365,503 |
| 2025-12-19 | Nuss John | CHIEF SCIENTIFIC OFFICER | Buy | 34,930 | $0 |
| 2025-12-19 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 12,675 | $97,851 |
| 2025-11-19 | Forman Mark S | Chief Medical Officer | Buy | 3,000 | $3,090 |
| 2025-11-19 | Gonzales Roy | Senior VP, Finance | Buy | 1,767 | $1,820 |
| 2025-05-16 | Forman Mark S | Chief Medical Officer | Buy | 3,000 | $3,090 |
| 2025-05-16 | Gonzales Roy | Senior VP, Finance | Buy | 1,750 | $1,802 |
| 2025-04-03 | Nuss John | CHIEF SCIENTIFIC OFFICER | Sell | 1,887 | $2,019 |
来源：SEC Form 4 申报文件 · 截至 2026-03-04